综述 |
|
|
|
|
混合表型急性白血病的细胞及分子遗传学研究进展 |
王谦,陈苏宁() |
苏州大学附属第一医院 江苏省血液研究所 苏州 215006 |
|
The Genetics of Mixed-phenotype Acute Leukemia |
WANG Qian,CHEN Su-ning() |
The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, Suzhou 215006, China |
[1] |
Vardiman J W, Thiele J, Arber D A , et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood, 2009,114(5):937-951.
|
[2] |
Arber D A, Orazi A, Hasserjian R , et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood, 2016,127(20):2391-2405.
|
[3] |
Matutes E, Pickl W F, Van’t Veer M , et al. Mixed-phenotype acute leukemia: clinical and laboratory features and outcome in 100 patients defined according to the WHO 2008 classification. Blood, 2011,117(11):3163-3171.
doi: 10.1182/blood-2010-10-314682
|
[4] |
Porwit A, Bene M C . Acute leukemias of ambiguous origin. Am J Clin Pathol, 2015,144(3):361-376.
|
[5] |
Munker R, Brazauskas R, Wang H L , et al. Allogeneic hematopoietic cell transplantation for patients with mixed phenotype acute leukemia. Biol Blood Marrow Transplant, 2016,22(6):1024-1029.
|
[6] |
Weinberg O K, Arber D A . Mixed-phenotype acute leukemia: historical overview and a new definition. Leukemia, 2010,24(11):1844-1851.
|
[7] |
Yan L, Ping N, Zhu M , et al. Clinical, immunophenotypic, cytogenetic, and molecular genetic features in 117 adult patients with mixed-phenotype acute leukemia defined by WHO-2008 classification. Haematologica, 2012,97(11):1708-1712.
|
[8] |
van den Ancker W, Terwijn M, Westers T M , et al. Acute leukemias of ambiguous lineage: diagnostic consequences of the WHO2008 classification. Leukemia, 2010,24(7):1392-1396.
|
[9] |
Atfy M ,Al Azizi N M,Elnaggar A M. Incidence of Philadelphia-chromosome in acute myelogenous leukemia and biphenotypic acute leukemia patients: and its role in their outcome. Leuk Res, 2011,35(10):1339-1344.
|
[10] |
Bhatia P, Binota J, Varma N , et al. A study on the expression of BCR-ABL transcript in mixed phenotype acute leukemia (MPAL) cases using the reverse transcriptase polymerase reaction assay (RT-PCR) and its correlation with hematological remission status post Initial induction therapy. Mediterr J Hematol Infect Dis, 2012,4(1):e2012024.
|
[11] |
Gerr H, Zimmermann M, Schrappe M , et al. Acute leukaemias of ambiguous lineage in children: characterization, prognosis and therapy recommendations. Br J Haematol, 2010,149(1):84-92.
|
[12] |
Arana-Trejo R M, Ruiz Sanchez E, Ignacio-Ibarra G , et al. BCR/ABL p210, p190 and p230 fusion genes in 250 Mexican patients with chronic myeloid leukaemia (CML). Clin Lab Haematol, 2002,24(3):145-150.
|
[13] |
Moorman A V, Harrison C J, Buck G A , et al. Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial. Blood, 2007,109(8):3189-3197.
|
[14] |
Kihara R, Nagata Y, Kiyoi H , et al. Comprehensive analysis of genetic alterations and their prognostic impacts in adult acute myeloid leukemia patients. Leukemia, 2014,28(8):1586-1595.
doi: 10.1038/leu.2014.55
|
[15] |
Ley T J, Miller C, Ding L , et al. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med, 2013,368(22):2059-2074.
|
[16] |
Soupir C P, Vergilio J A, Dal Cin P , et al. Philadelphia chromosome-positive acute myeloid leukemia: a rare aggressive leukemia with clinicopathologic features distinct from chronic myeloid leukemia in myeloid blast crisis. Am J Clin Pathol, 2007,127(4):642-650.
|
[17] |
Wolach O, Stone R M . How I treat mixed-phenotype acute leukemia. Blood, 2015,125(16):2477-2485.
|
[18] |
Wang Y, Gu M, Mi Y , et al. Clinical characteristics and outcomes of mixed phenotype acute leukemia with Philadelphia chromosome positive and/or bcr-abl positive in adult. Int J Hematol, 2011,94(6):552-555.
doi: 10.1007/s12185-011-0953-1
|
[19] |
Al-Seraihy A S, Owaidah T M, Ayas M , et al. Clinical characteristics and outcome of children with biphenotypic acute leukemia. Haematologica, 2009,94(12):1682-1690.
|
[20] |
Owaidah T M, Al Beihany A, Iqbal M A , et al. Cytogenetics, molecular and ultrastructural characteristics of biphenotypic acute leukemia identified by the EGIL scoring system. Leukemia, 2006,20(4):620-626.
|
[21] |
Shimizu H, Saitoh T, Machida S , et al. Allogeneic hematopoietic stem cell transplantation for adult patients with mixed phenotype acute leukemia: results of a matched-pair analysis. Eur J Haematol, 2015,95(5):455-460.
|
[22] |
Zhang Y, Wu D, Sun A , et al. Clinical characteristics, biological profile, and outcome of biphenotypic acute leukemia: a case series. Acta Haematol, 2011,125(4):210-218.
|
[23] |
Heesch S, Neumann M, Schwartz S , et al. Acute leukemias of ambiguous lineage in adults: molecular and clinical characterization. Ann Hematol, 2013,92(6):747-758.
doi: 10.1007/s00277-013-1694-4
|
[24] |
De Braekeleer E, Meyer C, Douet-Guilbert N , et al. Identification of MLL partner genes in 27 patients with acute leukemia from a single cytogenetic laboratory. Mol Oncol, 2011,5(6):555-563.
doi: 10.1016/j.molonc.2011.08.003
|
[25] |
Li Z, Luo R T, Mi S , et al. Consistent deregulation of gene expression between human and murine MLL rearrangement leukemias. Cancer Res, 2009,69(3):1109-1116.
|
[26] |
Wang Q F, Wu G, Mi S , et al. MLL fusion proteins preferentially regulate a subset of wild-type MLL target genes in the leukemic genome. Blood, 2011,117(25):6895-6905.
doi: 10.1182/blood-2010-12-324699
|
[27] |
Balgobind B V, Raimondi S C, Harbott J , et al. Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study. Blood, 2009,114(12):2489-2496.
|
[28] |
Tamai H, Yamaguchi H, Hamaguchi H , et al. Clinical features of adult acute leukemia with 11q23 abnormalities in Japan: a co-operative multicenter study. Int J Hematol, 2008,87(2):195-202.
doi: 10.1007/s12185-008-0034-2
|
[29] |
Manola K N . Cytogenetic abnormalities in acute leukaemia of ambiguous lineage: an overview. Br J Haematol, 2013,163(1):24-39.
|
[30] |
Rubnitz J E, Onciu M, Pounds S , et al. Acute mixed lineage leukemia in children: the experience of St Jude Children’s Research Hospital. Blood, 2009,113(21):5083-5089.
|
[31] |
Xu X Q, Wang J M, Lu S Q , et al. Clinical and biological characteristics of adult biphenotypic acute leukemia in comparison with that of acute myeloid leukemia and acute lymphoblastic leukemia: a case series of a Chinese population. Haematologica, 2009,94(7):919-927.
|
[32] |
Lou Z, Zhang C C, Tirado C A , et al. Infantile mixed phenotype acute leukemia (bilineal and biphenotypic) with t(10;11)(p12;q23);MLL-MLLT10. Leuk Res, 2010,34(8):1107-1109.
|
[33] |
Daigle S R, Olhava E J, Therkelsen C A , et al. Potent inhibition of DOT1L as treatment of MLL-fusion leukemia. Blood, 2013,122(6):1017-1025.
doi: 10.1182/blood-2013-04-497644
|
[34] |
Dawson M A, Prinjha R K, Dittmann A , et al. Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia. Nature, 2011,478(7370):529-533.
|
[35] |
Takahashi K, Wang F, Morita K , et al. Integrative genomic analysis of adult mixed phenotype acute leukemia delineates lineage associated molecular subtypes. Nat Commun, 2018,9(1):2670.
|
[36] |
Alexander T B, Gu Z, Iacobucci I , et al. The genetic basis and cell of origin of mixed phenotype acute leukaemia. Nature, 2018,562(7727):373-379.
|
[37] |
Quesada A E, Hu Z, Routbort M J , et al. Mixed phenotype acute leukemia contains heterogeneous genetic mutations by next-generation sequencing. Oncotarget, 2018,9(9):8441-8449.
|
[38] |
Eckstein O S, Wang L, Punia J N , et al. Mixed-phenotype acute leukemia (MPAL) exhibits frequent mutations in DNMT3A and activated signaling genes. Exp Hematol, 2016,44(8):740-744.
|
[39] |
Noronha E P ,Marques L V C,Andrade F G , et al. T-lymphoid/myeloid mixed phenotype acute leukemia and early T-cell precursor lymphoblastic leukemia similarities with NOTCH1 mutation as a good prognostic factor. Cancer Manag Res, 2019,11:3933-3943.
|
[40] |
Hou H A, Kuo Y Y, Liu C Y , et al. DNMT3A mutations in acute myeloid leukemia: stability during disease evolution and clinical implications. Blood, 2012,119(2):559-568.
doi: 10.1182/blood-2011-07-369934
|
[41] |
Xiao W, Bharadwaj M, Levine M , et al. PHF6 and DNMT3A mutations are enriched in distinct subgroups of mixed phenotype acute leukemia with T-lineage differentiation. Blood Adv, 2018,2(23):3526-3539.
|
[42] |
Alexander T B, Gu Z, Choi J K , et al. Genomic landscape of pediatric mixed phenotype acute leukemia. Blood, 2016,128:454.
|
[43] |
Neumann M, Vosberg S, Schlee C , et al. Mutational spectrum of adult T-ALL. Oncotarget, 2015,6(5):2754-2766.
|
[44] |
Van Vlierberghe P, Patel J, Abdel-Wahab O , et al. PHF6 mutations in adult acute myeloid leukemia. Leukemia, 2011,25(1):130-134.
doi: 10.1038/leu.2010.247
|
[45] |
Wang Q, Qiu H, Jiang H , et al. Mutations of PHF6 are associated with mutations of NOTCH1, JAK1 and rearrangement of SET-NUP214 in T-cell acute lymphoblastic leukemia. Haematologica, 2011,96(12):1808-1814.
doi: 10.3324/haematol.2011.043083
|
[46] |
Van Vlierberghe P, Palomero T, Khiabanian H , et al. PHF6 mutations in T-cell acute lymphoblastic leukemia. Nat Genet, 2010,42(4):338-342.
|
[47] |
Sood R, Kamikubo Y , Liu P Role of RUNX1 in hematological malignancies. Blood, 2017,129(15):2070-2082.
|
[48] |
Ohgami R S, Ma L, Merker J D , et al. Next-generation sequencing of acute myeloid leukemia identifies the significance of TP53, U2AF1, ASXL1, and TET2 mutations. Mod Pathol, 2015,28(5):706-714.
|
[49] |
Zhang L, Padron E, Lancet J . The molecular basis and clinical significance of genetic mutations identified in myelodysplastic syndromes. Leuk Res, 2015,39(1):6-17.
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|